Cargando…
Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
BACKGROUND: End-stage renal disease is the irreversible final stage of chronic kidney disease and is fatal when not managed by either transplantation or dialysis. Transplantation is generally preferred over dialysis. However, to prevent graft rejection or loss, lifelong immunosuppression is required...
Autores principales: | Muduma, Gorden, Shaw, Jane, Hart, Warren M, Odeyemi, Abayomi, Odeyemi, Isaac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226454/ https://www.ncbi.nlm.nih.gov/pubmed/25395839 http://dx.doi.org/10.2147/PPA.S69461 |
Ejemplares similares
-
Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant
por: Muduma, Gorden, et al.
Publicado: (2016) -
Evaluating the Cost-Effectiveness of Prolonged-Release Tacrolimus Relative to Immediate-Release Tacrolimus in Liver Transplant Patients Based on Data from Routine Clinical Practice
por: Muduma, Gorden, et al.
Publicado: (2016) -
Patient survey to identify reasons for non-adherence and elicitation of quality of life concepts associated with immunosuppressant therapy in kidney transplant recipients
por: Muduma, Gorden, et al.
Publicado: (2016) -
Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence
por: Muduma, Gorden, et al.
Publicado: (2014) -
Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)